Category:
Active Pharmaceutical Ingredients
CAS NO:
184475-35-2
Standard:
In-house Standards,
Iressa (Gefitinib) is a targeted kinase inhibitor primarily utilized in oncology. It functions by blocking epidermal growth factor receptor (EGFR) tyrosine kinase activity, thereby inhibiting tumor cell proliferation. The chemical structure is defined by the molecular formula C22H24ClFN4O3 and CAS number 184475-35-6.
Strictly contraindicated for patients without confirmed EGFR mutations due to lack of efficacy. Storage requires controlled room temperature away from moisture. Healthcare providers must monitor for interstitial lung disease and severe dermatological reactions during clinical administration.